| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.056 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |